Polymer Conjugation Technologies
Bioconjugation
services
From polymer selection and functionalization to analytical characterization and GMP manufacturing, discover Curapath’s integrated bioconjugation capabilities for therapeutics and medical devices.
Polymer-Drug Conjugates
Enhance drug stability, pharmacokinetics and therapeutic performance through advanced polymer-drug conjugation strategies using biodegradable and stealth polymer platforms.
Coming soon
Polymer-Protein conjugation
Develop protein conjugates using PEG, PSAR, PAOx and polyamino acid platforms to improve half-life, stability, targeting and overall therapeutic performance.
Coming soon
Polymer-Oligonucleotide Conjugation
Support next-generation nucleic acid therapeutics through tailored polymer conjugation strategies for siRNA, mRNA, ASOs and other oligonucleotide-based platforms.
Coming soon
Medical-device-functionalization
Functionalize biomaterials and medical device surfaces using specialty polymers for tissue engineering, wound care, ophthalmology, biosensors and advanced implants.
Coming soon
Polymer
Backbones
Discover Curapath’s portfolio of specialty polymer platforms, including PEG-based systems, polyamino acids, PSAR, PAOx and custom polymer architectures for conjugation.
Coming soon
